IO Biotech, Inc.·4

Mar 20, 5:35 PM ET

Sullivan Amy 4

4 · IO Biotech, Inc. · Filed Mar 20, 2023

Insider Transaction Report

Form 4
Period: 2023-03-17
Sullivan Amy
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-03-17$2.32/sh+25,000$58,01825,000 total
Footnotes (1)
  • [F1]The transaction was executed in multiple trades in prices ranging from $2.18 to $2.46, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4.xmlPrimary